Related Experiment Videos
The dexamethasone suppression test in psychiatry.
P R Joyce1, P J Brinded, D Sellman
1Affective Disorders Unit, Sunnyside Hospital, Christchurch.
The New Zealand Medical Journal
|March 25, 1987
Summary
The dexamethasone suppression test (DST) is not a reliable diagnostic tool for melancholia. While 52% of depressed patients were nonsuppressors, the test also showed high false positive rates in other psychiatric conditions.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Diagnostics
Background:
- The dexamethasone suppression test (DST) has been investigated as a potential biological marker for melancholic depression.
- Claims suggested the DST could be both sensitive and specific for diagnosing melancholia.
Purpose of the Study:
- To evaluate the diagnostic accuracy of the dexamethasone suppression test (DST) for melancholic depression.
- To assess the sensitivity and specificity of the DST in differentiating melancholia from other psychiatric conditions.
Main Methods:
- Meta-analysis of four separate studies involving patients with major depression.
- Inclusion of data from patients with mania, schizophrenia, and non-depressed abstinent alcoholism for comparison.
Main Results:
- 52% of patients with major depression exhibited DST nonsuppression.
- Significant rates of DST nonsuppression were also found in other groups: 11% of manic patients, 20% of schizophrenic patients, and 15% of abstinent alcoholics.
Conclusions:
- The dexamethasone suppression test (DST) demonstrates insufficient specificity to serve as a general diagnostic test for melancholic depression.
- Further research is needed to identify more accurate biological markers for melancholia.